Literature DB >> 17001205

Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators.

Hein Heidbüchel1, Domenico Corrado, Allessandro Biffi, Ellen Hoffmann, Nicole Panhuyzen-Goedkoop, Jan Hoogsteen, Pietro Delise, Per Ivar Hoff, Antonio Pelliccia.   

Abstract

This consensus paper on behalf of the Study Group on Sports Cardiology of the European Society of Cardiology follows a previous one on guidelines for sports participation in competitive and recreational athletes with supraventricular arrhythmias and pacemakers. The question of imminent life-threatening arrhythmias is especially relevant when some form of ventricular rhythm disorder is documented, or when the patient is diagnosed to have inherited a pro-arrhythmogenic disorder. Frequent ventricular premature beats or nonsustained ventricular tachycardia may be a hallmark of underlying pathology and increased risk. Their finding should prompt a thorough cardiac evaluation, including both imaging modalities and electrophysiological techniques. This should allow distinguishing idiopathic rhythm disorders from underlying disease that carries a more ominous prognosis. Recommendations on sports participation in inherited arrhythmogenic conditions and asymptomatic gene carriers are also discussed: congenital and acquired long QT syndrome, short QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, arrhythmogenic right ventricular cardiomyopathy and other familial electrical disease of unknown origin. If an implantable cardioverter defibrillator is indicated, it is no substitute for the guidelines relating to the underlying pathology. Moreover, some particular recommendations for patients/athletes with an implantable cardioverter defibrillator are to be observed.

Entities:  

Mesh:

Year:  2006        PMID: 17001205     DOI: 10.1097/01.hjr.0000239465.26132.29

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  33 in total

Review 1.  Long-range silencing and position effects at telomeres and centromeres: parallels and differences.

Authors:  S Perrod; S M Gasser
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

2.  DNA fragmentation in leukocytes following subacute low-dose nerve agent exposure.

Authors:  J R Moffett; R A Price; S M Anderson; M L Sipos; A V Moran; F C Tortella; J R Dave
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

Review 3.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.

Authors:  Thomas Herren; Philipp A Gerber; Firat Duru
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

Review 4.  Inherited primary arrhythmia disorders: cardiac channelopathies and sports activity.

Authors:  S Marrakchi; I Kammoun; E Bennour; L Laroussi; M Ben Miled; S Kachboura
Journal:  Herz       Date:  2018-05-09       Impact factor: 1.443

Review 5.  Athletes with Implantable Cardioverter Defibrillators.

Authors:  Shiva P Ponamgi; Christopher V DeSimone; Michael J Ackerman
Journal:  Clin Sports Med       Date:  2015-07       Impact factor: 2.182

Review 6.  Prevalence and spectrum diseases predisposing to sudden cardiac death: are they the same for both the athlete and the nonathlete?

Authors:  Anjan S Batra; Seshadri Balaji
Journal:  Pediatr Cardiol       Date:  2012-03       Impact factor: 1.655

7.  Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.

Authors:  E Fernlund; C Lundin; E Hertervig; O Kongstad; M Alders; P Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09       Impact factor: 1.468

8.  Brugada syndrome: Controversies in Risk stratification and Management.

Authors:  Lm Nunn; J Bhar-Amato; Pd Lambiase
Journal:  Indian Pacing Electrophysiol J       Date:  2010-09-05

Review 9.  Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.

Authors:  Rainer Schimpf; Christian Veltmann; Christian Wolpert; Martin Borggrefe
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

Review 10.  Arrhythmogenic right ventricular cardiomyopathy: diagnosis and risk stratification.

Authors:  Leif-Hendrik Boldt; Wilhelm Haverkamp
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.